John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMA
101
DELISTED
Comerica
CMA
| $51.8M | 0.24% |
1,148,547
-348,158
| -23% | -$15.5M |
|
|
PRE
102
DELISTED
PARTNERRE LTD
PRE
| $51.8M | 0.24% |
452,888
+376,248
| +491% | +$43.2M |
|
103
Eaton
ETN
$163B
| $51.7M | 0.24% |
761,456
+758,417
| +24,956% | +$51.6M |
|
104
NOV
NOV
$7.28B
| $51.4M | 0.24% |
1,027,967
+955,059
| +1,310% | +$51.8M |
|
105
Netflix
NFLX
$331B
| $51.2M | 0.24% |
+8,598,520
| New | +$52.2M |
|
106
Micron Technology
MU
$1.09T
| $50.6M | 0.24% |
1,866,360
-1,193,076
| -39% | -$35.7M |
|
107
CBRE Group
CBRE
$44B
| $50.3M | 0.23% |
1,300,566
+766,258
| +143% | +$26.4M |
|
|
CPN
108
DELISTED
Calpine Corporation
CPN
| $50.3M | 0.23% |
2,200,662
+410,876
| +23% | +$8.86M |
|
|
TCO
109
DELISTED
Taubman Centers Inc.
TCO
| $50.2M | 0.23% |
650,625
+484,189
| +291% | +$38.2M |
|
110
Starbucks
SBUX
$122B
| $49.9M | 0.23% |
1,054,294
+771,412
| +273% | +$34.7M |
|
111
Alcoa
AA
$13.7B
| $49.9M | 0.23% |
+1,606,792
| New | +$57.7M |
|
112
Trane Technologies
TT
$99.8B
| $49.7M | 0.23% |
729,979
+444,394
| +156% | +$29.4M |
|
113
Carnival Corporation Ltd
CCL
$35.2B
| $49.2M | 0.23% |
1,028,452
+217,459
| +27% | +$9.79M |
|
114
Air Products & Chemicals
APD
$67.9B
| $49M | 0.23% |
350,388
-63,714
| -15% | -$8.81M |
|
115
Allison Transmission
ALSN
$11B
| $49M | 0.23% |
1,533,225
+81,593
| +6% | +$2.62M |
|
116
Boeing
BA
$169B
| $48.7M | 0.23% |
+324,539
| New | +$47.2M |
|
117
Universal Health Services
UHS
$10.4B
| $48.5M | 0.23% |
411,996
+315,113
| +325% | +$34.9M |
|
118
Boston Scientific
BSX
$73B
| $48.1M | 0.22% |
2,711,834
-5,806,180
| -68% | -$91.8M |
|
|
GGP
119
DELISTED
GGP Inc.
GGP
| $47.7M | 0.22% |
+1,614,752
| New | +$48.2M |
|
120
Oceaneering
OII
$5.28B
| $47M | 0.22% |
+870,815
| New | +$46.5M |
|
121
Coca-Cola
KO
$392B
| $46.9M | 0.22% |
+1,157,309
| New | +$48.4M |
|
122
Hasbro
HAS
$13.2B
| $46.7M | 0.22% |
+738,804
| New | +$43.4M |
|
123
Royal Bank of Canada
RY
$285B
| $45.8M | 0.21% |
760,899
+744,473
| +4,532% | +$45.8M |
|
|
SEE
124
DELISTED
Sealed Air
SEE
| $45.6M | 0.21% |
1,000,231
-254,044
| -20% | -$11.3M |
|
|
PPLI
125
People Inc
PPLI
$2.86B
| $44.5M | 0.21% |
3,688,185
+481,463
| +15% | +$5.57M |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.